Clinical trial
Perioperative Inflammation and Cyclooxygenase 2 (COX-2)
NCT00122096 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00122096 |
|---|---|
| Title | Perioperative Inflammation and Cyclooxygenase 2 (COX-2) |
| Official title | Preoperative Valdecoxib: CNS Penetration and Effects on Biochemical Markers of Pain and Sensitization |
| Lead sponsor | University of Washington, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Neurosurgery, Pain |
| Intervention type | Drug |
| Interventions | valdecoxib |
| Enrollment | 30 |
| Start date | Nov 1, 2002 |
| Completion | Jan 1, 2006 |
| First posted | Jul 21, 2005 |
| Last update posted | Sep 26, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: